Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 12.3984 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 12.5037 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 12.5292 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 12.0207 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 12.4669 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 12.6437 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 12.6034 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 12.3527 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 12.2238 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 12.5083 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 12.5179 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 12.4729 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 12.5235 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 12.4575 | 99 |